Red blood cell alloimmunization in sickle cell disease and in thalassaemia: current status, future perspectives and potential role of molecular typing

A Matteocci, L Pierelli - Vox sanguinis, 2014 - Wiley Online Library
Red blood cell (RBC) transfusions are a milestone in the treatment for sickle cell anaemia
(SSA) and for thalassaemia. RBC alloimmunization remains a major challenge of chronic …

Red cell transfusion and the immune system

S Hart, CM Cserti‐Gazdewich, SA McCluskey - Anaesthesia, 2015 - Wiley Online Library
Understanding the complex immunological consequences of red cell transfusion is essential
if we are to use this valuable resource wisely and safely. The decision to transfuse red cells …

BGMUT: NCBI dbRBC database of allelic variations of genes encoding antigens of blood group systems

SK Patnaik, W Helmberg… - Nucleic acids research, 2012 - academic.oup.com
Analogous to human leukocyte antigens, blood group antigens are surface markers on the
erythrocyte cell membrane whose structures differ among individuals and which can be …

[HTML][HTML] ABO and Rhesus (D) blood group distribution among blood donors in rural south western Uganda: a retrospective study

RO Apecu, EM Mulogo, F Bagenda, A Byamungu - BMC research notes, 2016 - Springer
Abstract Background In Uganda, geographical distribution of blood groups and Rhesus (D)
factor varies across the country. The aim of this study was to examine the distribution of …

Forssman expression on human erythrocytes: biochemical and genetic evidence of a new histo-blood group system

L Svensson, AK Hult, R Stamps… - Blood, The Journal …, 2013 - ashpublications.org
In analogy with histo-blood group A antigen, Forssman (Fs) antigen terminates with α3-N-
acetylgalactosamine and can be used by pathogens as a host receptor in many mammals …

[HTML][HTML] Variant RH alleles and Rh immunisation in patients with sickle cell disease

E Sippert, CR Fujita, D Machado, G Guelsin… - Blood …, 2015 - ncbi.nlm.nih.gov
Background Alloimmunisation is a major complication in patients with sickle cell disease
(SCD) receiving red blood cell (RBC) transfusions and despite provision of Rh phenotyped …

Matrix-assisted laser desorption/ionisation, time-of-flight mass spectrometry–based blood group genotyping—the alternative approach

C Gassner, S Meyer, BM Frey, C Vollmert - Transfusion Medicine Reviews, 2013 - Elsevier
Although matrix-assisted laser desorption/ionisation, time-of-flight mass spectrometry
(MALDI-TOF MS) has previously been reported for high throughput blood group genotyping …

[HTML][HTML] ABH-glycan microarray characterizes ABO subtype antibodies: fine specificity of immune tolerance after ABO-incompatible transplantation

M Jeyakanthan, PJ Meloncelli, L Zou, TL Lowary… - American Journal of …, 2016 - Elsevier
Organ transplantation from ABO blood group–incompatible (ABOi) donors requires accurate
detection, effective removal and subsequent surveillance of antidonor antibodies. Because …

Immunohematologic tolerance of chronic transfusion exchanges with erythrocytapheresis in sickle cell disease

JM Michot, F Driss, C Guitton, J Moh Klaren… - …, 2015 - Wiley Online Library
Background Sickle cell disease (SCD) has become a major public health issue.
Hydroxyurea and red blood cell (RBC) transfusion are the cornerstone treatments …

D category IV: a group of clinically relevant and phylogenetically diverse partial D

I von Zabern, FF Wagner, JM Moulds, JJ Moulds… - …, 2013 - Wiley Online Library
Background The D typing strategies in several E uropean countries protect carriers of D
category VI (DVI) from anti‐D immunization but not carriers of other partial D. Besides DVI …